An observational study in ST-segment Elevation Myocardial Infarction (STEMI), sponsored by Universitas Diponegoro. Recruiting at 1 site in Indonesia. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by Universitas Diponegoro · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in ST Elevation Myocardial Infarction with a site in Indonesia — 4 open to participants now, 4 under way, 1 of them phase 3. ST Elevation Myocardial Infarction · Indonesia.
Among the 15 studies in ST Elevation Myocardial Infarction with a site in Indonesia, this one is one of 5 that started in 2024, is one of 3 observational ones, and was the 9th registered.
855 studies on the registry are indexed under ST Elevation Myocardial Infarction; 201 are open to participants now.
Browse ST Elevation Myocardial Infarction studies →4 of the 15 studies in ST Elevation Myocardial Infarction with a site in Indonesia are open now. Recruiting first, the newest first:
Universitas Diponegoro · Sites in Indonesia
Ages 18–75
Universitas Diponegoro · Sites in Indonesia
Ages 18–70
Indonesia University · Sites in Indonesia
Ages 30–70
A study can be open while its sites in Indonesia have not opened yet or have stopped. Only those recruiting at a site in Indonesia →
Of the 124 ST Elevation Myocardial Infarction studies recruiting now, 78 (63%) set no upper age limit and 20 (16%) stop at 75 or younger; 10 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 3 · Phase 4 2
First in 2016; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is below the median of 340 across 298 observational studies indexed under ST Elevation Myocardial Infarction.
Median enrollment 62 across the 12 interventional studies, 217 across the 3 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 15 have an industry lead sponsor. The 10 most frequent:
Universitas Diponegoro is the lead sponsor of 23 studies on the registry; 11 are open to participants now.
Universitas Diponegoro has 5 studies filed under ST Elevation Myocardial Infarction — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 15 studies in ST Elevation Myocardial Infarction with a site in Indonesia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate the prognostic value of the anion gap in predicting major adverse cardiovascular events among patients with ST-segment elevation myocardial infarction. Researchers will collect information based on hospital registry as secondary data of in patient who had diagnosed as ST-segment elevation myocardial infarction and underwent primary percutaneous coronary intervention. The data consist of demographic data, clinical presentation, laboratory, and angiography result were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.
Patient with ST-segment elevation myocardial infarction who underwent PPCI
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patient with STEMI who suffered major adverse cardiovascular events (MACE) after underwent primary percutaneous coronary intervention (PPCI)
Diagnostic Test: Anion gap
Patient was taken blood examination before PPCI
Major Adverse Cardiovascular Events (MACE)
Time frame: During hospitalization, up to 1 weeks
Incidence of mortality
Time frame: During hospitalization, up to 1 weeks
Incidence of reinfarction
Time frame: During hospitalization, up to 1 weeks
Incidence of stroke
Time frame: During hospitalization, up to 1 weeks
Incidence of lethal arrhythmia
Time frame: During hospitalization, up to 1 weeks
Incidence of acute lung oedema
Time frame: During hospitalization, up to 1 weeks
Incidence of cardiogenic shock
Time frame: During hospitalization, up to 1 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2024 to primary completion in Jun 2024, 5 months.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
ST Elevation Myocardial Infarction →
Universitas Diponegoro